The 3nd roundtable debate of the European Network for Safer Healthcare was organised by Health First Europe in the European Parliament on 25 September 2019, with the support of MEP Simona Bonafe (EPP, Portugal) and MEP Lieve Wierinck (ALDE, Belgium),.
The City-Labs Talk Series meeting “Tackling Heart Failure in Europe: Accessing Innovation & Fostering Integrated Care” took place on September 11th, 2019. The aim was to discuss how to improve care to tackle the burden of heart failure, from diagnosis and prevention to reduction of risk of death throughout integrated care models and solutions.
On 18 June 2019, Health First Europe as partner of My City-Lab organised a workshop, on the future of digital skills and innovation in EHMA 2019 Conference.
The City-Labs Talk Series meeting “A greener health: how to foster environmental sustainability in health care” took place on May 14th, 2019. The aim was to discuss to what extent healthcare systems could reduce their environmental footprint, without affecting delivery and quality of care.
Personalised medicine become a key topic in EU health debate, with its goal of giving the right treatment to the right patient at the right time. On 27-28 March 2018, the European Alliance for Personalised Medicine & Bulgaria Alliance for Person and Personalised Medicine organised the conference “Personalised Medicine and the Big Data Challenge”.
The 2nd roundtable debate of the European Network for Safer Healthcare was organised by Health First Europe in the European Parliament on 29 January 2019, with the support of MEP José Inácio Faria (EPP, Portugal) and MEP Lieve Wierinck (ALDE, Belgium),.
The third meeting of the City-Labs Talk Series took place on November 22nd, 2018. The event, entitled “Diabetes care in the digital age: accessing innovation & fostering self-care”, was organised by the City-Labs team to discuss the impact of digital solutions on the improvement of diabetes care and how promoting access to these technologies can enhance quality of care.
The second meeting of the City-Labs Talk Series was entitled “Biobanking: indispensable tool or ethical concern?” to discuss to what extent public health could benefit from biobanking. Key future ethical and technical challenges were also discussed.
The first meeting of the City-Labs Talk Series took place on July 9th, 2018. The event, entitled “Applications of Artificial Intelligence (AI) in health: to solve societal challenges or to become one?”, was organised by City-Labs team to discuss applications of Artificial Intelligence (AI) in health and medical laboratory and what are the key challenges ahead.
On 7 June 2018, policymakers and health representatives met within the framework of the European Parliament Interest Group on Innovation in Health and Social Care.
On 6th March 2018, in conjunction with the World Hearing Day, policymakers and EU stakeholders, met in the European Parliament to raise awareness on the social and economic impact of hearing loss in our society.
On 29th January 2018, To-Reach and Health First Europe co-organised a joint workshop entitled Identifying and transferring innovation in comparative Health Services and Systems Research.
On 5 December 2017, policymakers and health representatives met to discuss and assess the current situation of patient safety in Europe and how eHealth technology could reduce adverse events in all healthcare settings.
On 28 Nov 2017, policymakers & health representatives met to spur debate on the role of innovation in supporting the re-organisation of health workers.
On 31st May 2017, policymakers and health representatives met within the framework of the European Parliamentary Interest Group on Innovation on health and social care to spur debate on innovative diagnostic solutions necessary to manage and fight antimicrobial resistance (AMR) in Europe.
On 17th November 2016, in conjunction with the World Antibiotic Awareness Week, policy makers and health stakeholders met within the framework of the EP Interest Group on Innovation on health and social care to discuss how to tackle the global threat of antimicrobial resistance to improve patient safety.
